True North Advisors, LLC Gsk PLC Transaction History

True North Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$42.05 - $47.77 $949,825 - $1.08 Million	-22,588 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$40.23 - $47.74 $7,643 - $9,070	-190 Reduced 0.83%	22,588 $983,000
Q4 2021 Feb 11, 2022	BUY	$38.88 - $45.31 $38 - $45	1 Added 0.0%	22,778 $1 Million
Q3 2021 Jun 07, 2022	SELL	$38.79 - $43.16 $1,784 - $1,985	-46 Reduced 0.2%	22,777 $870,000
Q2 2021 Jun 07, 2022	SELL	$36.52 - $41.46 $146 - $165	-4 Reduced 0.02%	22,823 $908,000
Q1 2021 Jun 07, 2022	SELL	$34.27 - $40.01 $12,782 - $14,923	-373 Reduced 1.61%	22,827 $814,000
Q4 2020 May 20, 2022	SELL	$34.07 - $39.94 $151,952 - $178,132	-4,460 Reduced 16.12%	23,200 $853,000
Q3 2020 May 20, 2022	BUY	$38.11 - $42.99 $15,815 - $17,840	415 Added 1.52%	27,660 $1.04 Million
Q2 2020 May 20, 2022	BUY	$37.87 - $43.58 $736,154 - $847,151	19,439 Added 249.03%	27,245 $1.11 Million
Q1 2020 May 12, 2022	BUY	$32.47 - $48.83 $3,701 - $5,566	114 Added 1.48%	7,806 $295,000
Q4 2019 May 12, 2022	BUY	$42.0 - $48.25 $323,064 - $371,139	7,692 New	7,692 $361,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True North Advisors, LLC with notifications on news.